David Gurwitz
Impact in
- Biological Psychiatry top 2%
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Receptor Mechanisms and Signaling 30
-
- Neuroscience and Neuropharmacology Research 23
- Neuropeptides and Animal Physiology 10
- Co-authors
- Dennis D. Cunningham (6 shared papers)Mordechai Sokolovsky (12 shared papers)Moshe Rehavi (10 shared papers)Abraham Fisher (11 shared papers)Jeantine E. Lunshof (10 shared papers)Abraham Weizman (8 shared papers)Noam Shomron (17 shared papers)Rachel Haring (13 shared papers)
- Journals
- Pharmacogenomics (19 papers)Biochemical and Biophysical Research Communications (10 papers)Drug Discovery Today (9 papers)Translational Psychiatry (6 papers)European Journal of Human Genetics (5 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
David Gurwitz
190 papers receiving 5.6k citations
David Gurwitz's Hit Papers
Peers
Comparison fields: 5 of 157
- Biological Psychiatry 158
- Pharmacology 513
- Hematology 574
- Cellular and Molecular Neuroscience 949
- Cancer Research 498
Countries citing papers authored by David Gurwitz
This map shows the geographic impact of David Gurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gurwitz more than expected).
Fields of papers citing papers by David Gurwitz
This network shows the impact of papers produced by David Gurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gurwitz. The network helps show where David Gurwitz may publish in the future.
Co-authors
The 25 scholars most cited alongside David Gurwitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics Hit paper breakdown → | 2020 | 572 |
| 2 | 1988 | 285 | |
| 3 | 2009 | 221 | |
| 4 | 1990 | 177 | |
| 5 | 2002 | 133 | |
| 6 | 2006 | 122 | |
| 7 | 1996 | 117 | |
| 8 | 1989 | 112 | |
| 9 | 1994 | 106 | |
| 10 | 2005 | 101 | |
| 11 | 2018 | 97 | |
| 12 | 2012 | 96 | |
| 13 | 2011 | 94 | |
| 14 | 2008 | 89 | |
| 15 | 2006 | 89 | |
| 16 | 2004 | 86 | |
| 17 | 2006 | 84 | |
| 18 | 1980 | 76 | |
| 19 | 2004 | 74 | |
| 20 | 1990 | 72 |
About David Gurwitz
David Gurwitz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Genetics, Pharmacology and Physiology, having authored 195 papers that have together received 5.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (30 papers), Pharmacogenetics and Drug Metabolism (25 papers), Neuroscience and Neuropharmacology Research (23 papers), Alzheimer's disease research and treatments (11 papers), Neuropeptides and Animal Physiology (10 papers), Computational Drug Discovery Methods (8 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Pharmaceutical studies and practices (8 papers). The work is most often cited by research in Biological Psychiatry (158 citations), Pharmacology (513 citations), Hematology (574 citations), Cellular and Molecular Neuroscience (949 citations) and Cancer Research (498 citations). David Gurwitz has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Dennis D. Cunningham, Mordechai Sokolovsky, Moshe Rehavi, Abraham Fisher, Jeantine E. Lunshof, Abraham Weizman, Noam Shomron, Rachel Haring, Ralph Bradshaw and Yoel Kloog. Their work appears in journals such as Pharmacogenomics, Biochemical and Biophysical Research Communications, Drug Discovery Today, Translational Psychiatry and European Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.